Beam Therapeutics (BEAM) Retained Earnings: 2019-2025
Historic Retained Earnings for Beam Therapeutics (BEAM) over the last 6 years, with Sep 2025 value amounting to -$1.9 billion.
- Beam Therapeutics' Retained Earnings fell 26.67% to -$1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 billion, marking a year-over-year decrease of 26.67%. This contributed to the annual value of -$1.6 billion for FY2024, which is 31.66% down from last year.
- According to the latest figures from Q3 2025, Beam Therapeutics' Retained Earnings is -$1.9 billion, which was down 5.56% from -$1.8 billion recorded in Q2 2025.
- In the past 5 years, Beam Therapeutics' Retained Earnings ranged from a high of -$599.2 million in Q1 2021 and a low of -$1.9 billion during Q3 2025.
- Over the past 3 years, Beam Therapeutics' median Retained Earnings value was -$1.4 billion (recorded in 2024), while the average stood at -$1.5 billion.
- Data for Beam Therapeutics' Retained Earnings shows a maximum YoY tumbled of 156.61% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Beam Therapeutics' Retained Earnings stood at -$768.3 million in 2021, then plummeted by 37.63% to -$1.1 billion in 2022, then dropped by 12.53% to -$1.2 billion in 2023, then crashed by 31.66% to -$1.6 billion in 2024, then dropped by 26.67% to -$1.9 billion in 2025.
- Its last three reported values are -$1.9 billion in Q3 2025, -$1.8 billion for Q2 2025, and -$1.7 billion during Q1 2025.